KEGG   DRUG: Sofosbuvir - velpatasvir mixtHelp
Entry
D10827            Mixture   Drug                                   

Name
Sofosbuvir - velpatasvir mixt;
Epclusa (TN)
Product
Component
Sofosbuvir [DR:D10366], Velpatasvir [DR:D10806]
Remark
ATC code: J05AP55
Product: D10827<US>
Efficacy
Antiviral
  Disease
Hepatitis C virus infection [DS:H00413]
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 J ANTIINFECTIVES FOR SYSTEMIC USE
  J05 ANTIVIRALS FOR SYSTEMIC USE
   J05A DIRECT ACTING ANTIVIRALS
    J05AP Antivirals for treatment of HCV infections
     J05AP55 Sofosbuvir and velpatasvir
      D10827  Sofosbuvir - velpatasvir mixt <US>
USP drug classification [BR:br08302]
 Antivirals
  Anti-hepatitis C (HCV) Agents, Direct Acting
   Sofosbuvir/Velpatasvir
    D10827  Sofosbuvir - velpatasvir mixt
Antiinfectives [br08350.html]
 Antivirals
  D10827
New drug approvals in the USA [br08319.html]
 New Molecular Entity and New Therapeutic Biological Product Approvals
  D10827
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D10827
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D10827
BRITE hierarchy
Other DBs
PubChem: 319902627
LinkDB All DBs

» Japanese version   » Back

DBGET integrated database retrieval system